Results 141 to 150 of about 28,810 (212)

HEPES in Cell Culture Alters the Multi-Omics Profile Exhibited by Gaucher Disease Fibroblasts. [PDF]

J Cell Biochem
Corazolla EM, Schomakers BV, Trętowicz MM, Hermans J, van Weeghel M, Vaz FM, Pras-Raves ML, Vlugt KG, Beers-Stet FS, Goorden SMI, Jansen-Meijer J, Janssens GE, Hollak CEM, Houtkooper RH, van Kuilenburg ABP.   +14 more
europepmc   +1 more source

Transcriptomic signatures in Gaucher disease subtypes: A systems biology perspective. [PDF]

Mol Genet Metab Rep
Elahimanesh M, Ganjali R, Najafi M.
europepmc   +1 more source

Multidrug resistance and myelomonocytic leukaemia in gaucher's disease [PDF]

, 2003
Baker, R, Ganeshaguru, K, Krishnan, B, Mehta, AB, Richfield, L   +4 more
core  

Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Saif M, Nasir A, Shafique S, Fatima M, Talha M.   +4 more
europepmc   +1 more source

Serum hepcidin as a biomarker of treatment response in Gaucher disease. [PDF]

Mol Genet Metab Rep
Koppe T, Pinheiro FC, Siebert M, Basgalupp S, Daudt LE, Schwartz IVD.   +5 more
europepmc   +1 more source

Gaucher disease, state of the art and perspectives. [PDF]

J Intern Med
Camou F, Berger MG.
europepmc   +1 more source

Gaucher Disease [PDF]

, 2019
openaire   +3 more sources

Precision genomic profiling in Gaucher disease: insights from atypical presentations. [PDF]

Front Genet
Saith A, Ain NU, Ruan J, Kasaiyan M, Jain D, Israel G, Mehta S, Bamford NS, Nair S, Mistry PK.   +9 more
europepmc   +1 more source

Microbiome-gut-heart axis in cardiac complications of Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Abedin ZU, Iqbal MU, Shahriar Z.
europepmc   +1 more source

Cytotoxic lymphocyte effector function is unaffected in patients with Gaucher disease. [PDF]

Front Immunol
Zou J, Noori T, Walterfang M, Szer J, Trapani JA, Voskoboinik I.   +5 more
europepmc   +1 more source